Lornoxicam injection is inferior to betamethasone in the treatment of subacromial impingement syndrome

详细信息    查看全文

• 作者：M. Aksakal ; C. Ermutlu ; G. Özkaya ; Y. Özkan
• 关键词：Shoulder ; Nonsteroidal anti ; inflammatory drugs ; Steroids ; Questionnaires ; Complications
• 刊名：Der Orthopäde
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：46
• 期：2
• 页码：179-185
• 全文大小：
• 刊物主题：Orthopedics; Chiropractic Medicine; Conservative Orthopedics; Surgical Orthopedics; Sports Medicine; Traumatic Surgery;
• 出版者：Springer Medizin
• ISSN：1433-0431
• 卷排序：46

文摘

BackgroundSubacromial impingement syndrome (SIS) is one of the most frequent shoulder pathologies. Initial treatment is conservative. Subacromial injection of drugs achieves a high concentration at the pathologic site with less drug use and fewer systemic side effects. Glucocorticoids are most frequently injected. One concern with steroid use is the wide array of potential systemic and local complications. Nonsteroidal anti-inflammatory drugs (NSAIDs) are also peripherally acting and can be used locally. Although intraarticular (IA) use of NSAIDs is common in orthopedic practice, it is mostly restricted to the knee joint. Reports of local NSAID for joint pathologies are relatively rare. This study compared the efficacy of single-dose subacromial injections of betamethasone and lornoxicam for treatment of SIS.